Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 17 of 17 entries
View as:

Intra-Tumoral Vascular Growth Patterns is a Robust Indicator of Adjuvant Therapy Following Liver Resection in HCC

Phase: N/A Priority: Normal
NCT ID: NCT06461936 Org: User:
Start: 01/01/19 End: 04/30/25 Due: 04/30/26

VETC is an Effective Marker for Postoperative Adjuvant Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06253364 Org: User:
Start: 01/01/19 End: 01/31/24 Due: 01/31/25

ML Models for Predicting Postoperative Peritoneal Metastasis After Hepatocellular Carcinoma Rupture

Phase: N/A Priority: Normal
NCT ID: NCT06102278 Org: User:
Start: 01/01/20 End: 04/01/23 Due: 04/01/24

Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model

Phase: N/A Priority: Normal
NCT ID: NCT06420440 Org: User:
Start: 06/01/24 End: 05/31/27 Due: 05/31/28

Precision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models

Phase: N/A Priority: Normal
NCT ID: NCT06463444 Org: User:
Start: 06/01/24 End: 06/30/26 Due: 06/30/27

Chen's U-Suture Technique for Pancreaticojejunostomy Following Pancreaticoduodenectomy

Phase: N/A Priority: Normal
NCT ID: NCT03767959 Org: User:
Start: 06/24/19 End: 07/31/21 Due: 07/31/22

Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04076631 Org: User:
Start: 08/01/19 End: 12/31/20 Due: 12/31/21

Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.

Phase: N/A Priority: Normal
NCT ID: NCT06311942 Org: User:
Start: 04/01/24 End: 12/31/28 Due: 12/31/29

A Long-term Survival Analysis of Different Surgical Method in Early Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05117047 Org: User:
Start: 02/14/15 End: 06/30/21 Due: 06/30/22

Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation

Phase: N/A Priority: Normal
NCT ID: NCT06248554 Org: User:
Start: 12/01/19 End: 12/31/24 Due: 12/31/25

Postoperative Adjuvant Therapy of HCC Based on PD-1

Phase: N/A Priority: Normal
NCT ID: NCT05307926 Org: User:
Start: 02/01/19 End: 08/20/22 Due: 08/20/23

Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelling

Phase: N/A Priority: Normal
NCT ID: NCT06298123 Org: User:
Start: 02/01/19 End: 02/01/23 Due: 02/01/24

Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT06248528 Org: User:
Start: 12/01/19 End: 12/31/24 Due: 12/31/25

Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06311929 Org: User:
Start: 04/01/24 End: 12/31/28 Due: 12/31/29

Recurrence Patterns and Cost-Effectiveness of Surgical Approaches in Early-Stage Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06776185 Org: User:
Start: 01/15/22 End: 11/15/24 Due: 11/15/25

Comparison of Chen's U-suture Technique with Duct-to-Mucosa Anastomosis and Invagination Pancreaticojejunostomy After Pancreaticoduodenectomy

Phase: N/A Priority: Normal
NCT ID: NCT06863389 Org: User:
Start: 01/31/14 End: 06/30/24 Due: 06/30/25

Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.

Phase: N/A Priority: Normal
NCT ID: NCT06311916 Org: User:
Start: 05/01/24 End: 12/31/28 Due: 12/31/29